The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Apetinil     N-ethyl-1-phenyl-propan-2- amine

Synonyms: Etilamfetamina, Etilamfetamine, Etilanfetamina, CHEMBL276443, SureCN162316, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

High impact information on d-N-Ethylamphetamine

 

Analytical, diagnostic and therapeutic context of d-N-Ethylamphetamine

  • Analysis of time-lapse changes of d- and l-enantiomers of racemic ethylamphetamine and stereoselective metabolism in rat urine by HPLC determination [6].
  • The urinary excretion of etilamfetamine (ethylamphetamine) and its major metabolite amphetamine in humans was followed over a period of several days after the oral administration of two formulations [7].
  • Characterization of optical activity and simultaneous analysis of racemic ethylamphetamine (EAMP) and its metabolites, as well as the urinary excretion of the optical isomers, were examined in rats by high-performance liquid chromatography (HPLC) [8].

References

  1. meta Substituted N-ethylamphetamine self injection responding in the rhesus monkey: structure-activity relationships. Tessel, R.E., Woods, J.H. J. Pharmacol. Exp. Ther. (1978) [Pubmed]
  2. Engineering of recombinant antibody fragments to methamphetamine by anchored periplasmic expression. Harvey, B.R., Shanafelt, A.B., Baburina, I., Hui, R., Vitone, S., Iverson, B.L., Georgiou, G. J. Immunol. Methods (2006) [Pubmed]
  3. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. Peters, F.T., Schaefer, S., Staack, R.F., Kraemer, T., Maurer, H.H. Journal of mass spectrometry : JMS. (2003) [Pubmed]
  4. Isomeric amphetamines--a problem for urinalysis? Smith, F.P., Kidwell, D.A. Forensic Sci. Int. (1991) [Pubmed]
  5. Structure-activity relationships among some d-N-alkylated amphetamines. Woolverton, W.L., Shybut, G., Johanson, C.E. Pharmacol. Biochem. Behav. (1980) [Pubmed]
  6. Analysis of time-lapse changes of d- and l-enantiomers of racemic ethylamphetamine and stereoselective metabolism in rat urine by HPLC determination. Nagai, T., Kamiyama, S., Matsushima, K. Journal of analytical toxicology. (1995) [Pubmed]
  7. The influence of diuretics on the excretion and metabolism of doping agents. III. Etilamfetamine. Delbeke, F.T., Debackere, M. Arzneimittel-Forschung. (1986) [Pubmed]
  8. Urinary output changes in racemic ethylamphetamine and optical activity discrimination in rat urine by HPLC analysis. Matsushima, K., Nagai, T., Kanaya, H., Kato, Y., Takahashi, M., Kamiyama, S. Nippon Hoigaku Zasshi (1998) [Pubmed]
 
WikiGenes - Universities